Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases

Hannes Vietzen(Medical University of Vienna), Paulus Rommer(Medical University of Vienna), Lisa Weidner(Harvard University), Christof Jungbauer(Paracelsus Medical University), Barbara Kornek(Medical University of Vienna), Gabriel Bsteh(Medical University of Vienna), S. Berger(Department of Virology), Markus Ponleitner(Medical University of Vienna), Kevin Rostásy(Witten/Herdecke University), Jeremy V. Camp(Medical University of Vienna), Markus Reindl(Innsbruck Medical University), Gregory Aaen(Loma Linda University), Eva‐Maria Wendel(Olgahospital), Soe Mar(St. Louis Children's Hospital), Georgia Koukou(Witten/Herdecke University), Romana Höftberger(Medical University of Vienna), Marianne Graninger(Medical University of Vienna), Laura M. Kühner(Department of Virology), Hans P. Lassmann(Medical University of Vienna), Elisabeth Puchhammer-Stöckl(Medical University of Vienna), Charlotte Pistorius(Austrian Red Cross), Henrieke Saucke(Witten/Herdecke University), Franziska Kauth(Witten/Herdecke University), S. Sommer(Witten/Herdecke University), Timothy E. Lotze(Texas Children's Hospital), Raphael Reinecke(Medical University of Vienna), Bianca Weinstock-Guttman(Jacobs Institute), Emmanuelle L. Waubant(University of California, San Francisco), Tanuja Chitnis(Harvard University), T. Charles Casper(University of Utah), Markus Breu(Medical University of Vienna), Thomas Berger(Medical University of Vienna), Lauren Krupp(New York University)
JAMA Neurology
March 9, 2026
Cited by 0


Related Papers